Lesaka Q1 FY27 In Line; FY27 Guidance Reaffirmed, Merchant EBITDA Down 51%
LSAK is trading near its 52-week low of $3.62 (14% above the low).
Summary
Lesaka reported Q1 FY2027 results in line with expectations and reaffirmed FY2027 guidance, but group Adjusted EBITDA fell 17% in ZAR on a 51% collapse in Merchant segment EBITDA.
Key Events · Earnings and Guidance · LSAK
-
Q1 FY2027 Results In Line
Net revenue rose 8% year-on-year in ZAR to ZAR 1.583B ($97.2M), while GAAP revenue was roughly flat at ZAR 3.006B ($184.6M).
-
Group EBITDA Down 17%
Group Adjusted EBITDA fell to ZAR 220.1M ($13.5M) from ZAR 266.2M, and Adjusted EPS dropped 26% to ZAR 0.72 from ZAR 0.97.
-
Merchant Segment Halves
Merchant Segment Adjusted EBITDA fell 51% year-on-year in ZAR to ZAR 76.9M, only partly offset by Consumer (+38%) and Enterprise (+28%).
-
FY2027 Guidance Reaffirmed
Net revenue ZAR 7.0-7.7B, Group Adjusted EBITDA ZAR 1.45-1.60B and Adjusted EPS ZAR 7.50-8.50, with the midpoint implying 23% EPS growth.
Analysis · LSAK · Finance
Lesaka's first quarter of FY2027 came in roughly as management expected, and the company reaffirmed full-year guidance that at the midpoint implies Adjusted EPS of ZAR 8.00, up 23% year-on-year. The problem is mix: group Adjusted EBITDA fell 17% in ZAR to ZAR 220.1M as Merchant segment Adjusted EBITDA dropped 51% to ZAR 76.9M, offset only partly by Consumer (+38%) and Enterprise (+28%). GAAP swung to a ZAR 17.2M operating loss from a small profit a year earlier, and operating cash flow went to -$6.8M from +$8.9M, so the reaffirmation rests on a second-half recovery. Guidance includes the pending Bank Zero acquisition, which still needs South African Reserve Bank approval.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LSAK was trading at $4.14 on NASDAQ in the Finance sector, with a market capitalization of approximately $355.2M. The 52-week trading range was $3.62 to $5.54. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.